Cargando…
Change in Hematologic Indices over Time in Pediatric Inflammatory Bowel Disease Treated with Azathioprine
Azathioprine leads to changes in mean corpuscular volume (MCV) and white blood cell (WBC) indices reflecting efficacy or toxicity. Understanding the interactions between bone marrow stem cells and azathioprine could highlight abnormal response patterns as forerunners for hematologic malignancies. Th...
Autores principales: | Soman, Sherman, Ashok, Dhandapani, Connolly, Sally A., Cordell, Samantha J., Taylor, Chris J., Campbell, David I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586161/ https://www.ncbi.nlm.nih.gov/pubmed/21171667 http://dx.doi.org/10.2165/11539930-000000000-00000 |
Ejemplares similares
-
Azathioprine with Allopurinol: Lower Deoxythioguanosine in DNA and Transcriptome Changes Indicate Mechanistic Differences to Azathioprine Alone
por: Coulthard, Sally A., et al.
Publicado: (2017) -
Adverse Events Associated with Azathioprine Treatment in Korean Pediatric Inflammatory Bowel Disease Patients
por: Chun, Ji Young, et al.
Publicado: (2013) -
Azathioprine in inflammatory bowel disease, a safe alternative?
por: Tanis, A A
Publicado: (1998) -
Monitoring and Safety of Azathioprine Therapy in Inflammatory Bowel Disease
por: Kim, Mi Jin, et al.
Publicado: (2013) -
Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases
por: van Liere, Elsa L. S. A., et al.
Publicado: (2021)